| Type: | Subsidiary |
| Traded As: | NASDAQ: |
| Industry: | Pharmaceuticals & Biotechnology |
| Foundation: | Charlottesville, Virginia, U.S. |
| Location City: | Raleigh, North Carolina |
| Parent: | ICON plc |
| Location Country: | U.S. |
| Area Served: | Worldwide |
| Key People: | Colin Shannon (President and CEO) |
| Num Employees: | 17,000+[1] |
PRA Health Sciences was a contract research organization (CRO) with headquarters in Raleigh, North Carolina. It was established in 1976 and acquired by ICON in 2021.
PRA was founded as the Anti-Inflammatory Drug Study Group in 1976, renamed PRA in 1982, as it expanded into other therapeutic areas besides inflammation.[2] In 2013 the company was acquired by Kohlberg Kravis Roberts, which brought the company public in November 2014 and maintained shares until September 2019.[3] In August 2017, the company acquired Conshohocken-based real-world healthcare data, analytics, and technology solutions company Symphony Health for US$530 million.[4] PRA's 2018 revenue was US$2.87 billion.[5] PRA was acquired by ICON PLC on 1 July 2021.[6]